Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

Unlocking The Value Of Intellectual Property Financing Solutions For Smes

Industry news, News 13/08/2024

The Rise of IP-Backed Financing for SMEs

Taster Day 2024 (3)

Events, News, Team news 07/08/2024

Secerna Inspires Next Generation of Patent Attorneys

IPO Image Istock

Industry news, News 01/08/2024

Standard Essential Patents Resource Hub launched by UK IPO

UK Court Of Appeal

Industry news, News 24/07/2024

UK Court of Appeal clarifies patentability of AI

United States Patent And Trademark Office

Industry news, News 19/07/2024

The USPTO Clarifies Path for Patenting AI Inventions

Announcement (2)

News 19/07/2024

Secerna Unveils New Website and Email Addresses!

Uzbekistan

European, News 12/07/2024

UK IPO and Ministry of Justice of Uzbekistan Sign Memorandum of Understanding

Generative AI

Industry news, News 05/07/2024

WIPO Report: Generative AI Patent Landscape Thriving

Secerna Celebrates All Three Of This Year’S Candidates Passing The Eqes!

News, Team news, Careers 02/07/2024

Secerna celebrates all three of this year’s candidates passing the EQEs

5 6 7 8 9 10 11 12 13 14 15